Voyager Therapeutics, Inc.

NasdaqGS:VYGR Stok Raporu

Piyasa değeri: US$381.7m

Voyager Therapeutics Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Voyager Therapeutics 'in gelir ve kazançlarının sırasıyla yıllık 7.5% ve 23.5% oranında düşmesi öngörülüyor. EPS'nin yıllık 13.2% oranında düşüşmesi bekleniyor. Öz sermaye getirisinin 3 yıl içinde -27% olması öngörülüyor.

Anahtar bilgiler

-23.5%

Kazanç büyüme oranı

-13.2%

EPS büyüme oranı

Biotechs kazanç büyümesi27.0%
Gelir büyüme oranı-7.5%
Gelecekteki özkaynak getirisi-27.0%
Analist kapsamı

Good

Son güncelleme01 Nov 2024

Gelecekteki son büyüme güncellemeleri

Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 09
Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Recent updates

Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified

Oct 17
Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified

Voyager Therapeutics: CNS Player In Early Stages Of A Turnaround

Aug 26

Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Aug 09
Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S

Aug 08
Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S

Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis

Jun 05

There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise

Mar 15
There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise

Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier

Mar 08

What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates

Mar 04
What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement

Jan 04
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement

Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target

Oct 04

Voyager Therapeutics hires new finance chief

Sep 07

Voyager Therapeutics GAAP EPS of -$0.50 misses by $0.02

Aug 04

Looking Back In On Voyager Therapeutics

Jun 08

Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates

May 12
Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates

Voyager Does A Reboot After First Generation Failures

Mar 25

Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky

Feb 07
Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky

Voyager Therapeutics: Another Year, Another Deal

Nov 21

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:VYGR - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202667-110-90-837
12/31/202563-109-117-11110
12/31/202472-75-30-2510
6/30/20241449-22-18N/A
3/31/2024119-3813N/A
12/31/20232501327578N/A
9/30/2023158528689N/A
6/30/2023195969194N/A
3/31/2023191997477N/A
12/31/202241-46-15-13N/A
9/30/202271-17911N/A
6/30/202231-6046N/A
3/31/202232-7112N/A
12/31/202137-71-55-54N/A
9/30/202116-93-92-87N/A
6/30/202113218-100-91N/A
3/31/202116039-100-89N/A
12/31/202017137-109-97N/A
9/30/202019740-110-98N/A
6/30/2020100-61-103-95N/A
3/31/2020117-41-113-105N/A
12/31/2019104-444149N/A
9/30/201974-544348N/A
6/30/201955-594752N/A
3/31/201912-965761N/A
12/31/20188-88-20-16N/A
9/30/201812-78-10-6N/A
6/30/201811-81-8-5N/A
3/31/201810-74N/A2N/A
12/31/201710-71N/A-61N/A
9/30/20176-74N/A-60N/A
6/30/20178-59N/A-54N/A
3/31/201711-50N/A-47N/A
12/31/201614-40N/A-42N/A
9/30/201617-34N/A-39N/A
6/30/201618-32N/A-36N/A
3/31/201620-30N/A-33N/A
12/31/201517-38N/A41N/A
9/30/201512-35N/A46N/A
6/30/20157-32N/A50N/A
3/31/20153-30N/A55N/A
12/31/2014N/A-18N/A-12N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: VYGR şirketinin kazançlarının önümüzdeki 3 yıl içinde düşmesi öngörülüyor (yılda -23.5% ).

Kazançlar ve Piyasa: VYGR şirketinin kazançlarının önümüzdeki 3 yıl içinde düşmesi öngörülüyor (yılda -23.5% ).

Yüksek Büyüme Kazançları: VYGR şirketinin kazançlarının önümüzdeki 3 yıl içinde düşmesi öngörülüyor.

Gelir ve Pazar: VYGR şirketinin gelirinin önümüzdeki 3 yıl içinde düşmesi bekleniyor (yılda -7.5% ).

Yüksek Büyüme Geliri: VYGR şirketinin gelirinin önümüzdeki 3 yıl içinde düşmesi öngörülüyor (yılda -7.5% ).


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: VYGR 3 yıl içinde kârsız olması bekleniyor.


Büyüyen şirketleri keşfedin